Page last updated: 2024-11-02

phenobarbital and Acute Lymphoid Leukemia

phenobarbital has been researched along with Acute Lymphoid Leukemia in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
"A possible pharmacokinetic interaction between teniposide and anticonvulsant medications was evaluated in pediatric patients."1.28Increased teniposide clearance with concomitant anticonvulsant therapy. ( Baker, DK; Christensen, ML; Evans, WE; Pui, CH; Relling, MV; Rodman, JH, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, DK1
Relling, MV1
Pui, CH1
Christensen, ML1
Evans, WE1
Rodman, JH1

Other Studies

1 other study available for phenobarbital and Acute Lymphoid Leukemia

ArticleYear
Increased teniposide clearance with concomitant anticonvulsant therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2

    Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Int

1992